Cost is one of the biggest barriers to GLP-1 treatment. Without insurance, these medications can cost $1,000-1,500 per month. The good news: coverage is improving, and there are multiple pathways to make treatment affordable, often $0-25/month out of pocket.
Here's what you need to know about navigating insurance for your child's treatment.
The current coverage landscape
Coverage for GLP-1 medications varies significantly by plan type:
Commercial insurance (employer-sponsored)
Many commercial plans cover FDA-approved GLP-1 medications for adolescents with obesity when prescribed by a qualified physician. Coverage typically requires prior authorization demonstrating medical necessity (BMI ≥95th percentile, failed lifestyle interventions).
Marketplace plans (ACA)
Coverage varies by state and plan tier. Some ACA plans include obesity medications in their formulary; others exclude them. Check plan documents or your insurer directly for benefit details; if treatment is clinically appropriate, our team manages prior authorization and supports appeals after denials.
Medicaid / CHIP
Medicaid coverage for obesity medications is expanding but remains inconsistent across states. Some state Medicaid programs cover GLP-1 medications for adolescents; others do not. We help families navigate state-specific options.
How prior authorization works
Most insurance plans require prior authorization (PA) before covering GLP-1 medications. This means your physician must submit documentation proving medical necessity. Here's what that typically involves:
Thryvwell handles this entire process. Our team submits prior authorizations, tracks status, and files appeals if needed - so you don't have to navigate insurance bureaucracy yourself.
Want a real number for your family? Take the 2-minute eligibility check and we'll walk you through coverage and savings options that apply to you.
If coverage is denied
A denial isn't the end. Many initial denials are overturned on appeal, especially for adolescents with documented medical necessity. Beyond appeals, there are additional pathways:
Our team explains the available pathways and manages prior authorization and appeals, so families do not have to navigate the process alone.
Cost pathways to explore
Medication cost depends on your plan, pharmacy, and eligibility for manufacturer savings. Thryvwell does not verify benefits or promise a cost; when treatment is clinically appropriate, our team manages prior authorization and supports appeals after denials.
Sources
- Novo Nordisk. NovoCare® Patient Savings Program (2024)
- Eli Lilly. Zepbound® Savings Card Program (2024)
- Obesity Coverage Gap Report. Obesity Care Advocacy Network (2023)
We handle the insurance
Prior auth, appeals, savings programs - our team manages it all so you can focus on your child
The information on this page is for educational purposes only and does not constitute medical or financial advice. Coverage details vary by plan. Always verify with your insurance provider.
